Published in Ann Surg on December 01, 2006
Surgical treatment for anorectal malignant melanoma: report of five cases and review of 79 Japanese cases. Int J Colorectal Dis (2008) 1.50
Neoplasms of anal canal and perianal skin. Clin Colon Rectal Surg (2011) 1.28
Practice patterns and outcomes for anorectal melanoma in the USA, reviewing three decades of treatment: is more extensive surgical resection beneficial in all patients? Ann Surg Oncol (2009) 1.25
Ipilimumab for patients with advanced mucosal melanoma. Oncologist (2013) 1.09
Endobronchial metastasis from primary anorectal melanoma. Am J Case Rep (2013) 1.09
Malignant melanoma of the anorectum--a rare entity. Langenbecks Arch Surg (2010) 1.05
Anorectal melanoma. Clin Colon Rectal Surg (2011) 0.99
Anal versus rectal melanoma: does site of origin predict outcome? Dis Colon Rectum (2013) 0.97
Anorectal melanoma. Clin Colon Rectal Surg (2009) 0.97
Anorectal malignant melanomas: retrospective experience with surgical management. World J Gastroenterol (2011) 0.96
Diffuse anorectal melanoma; review of the current diagnostic and treatment aspects based on a case report. World J Surg Oncol (2009) 0.95
Rare presentations of primary melanoma and special populations: a systematic review. Am J Clin Oncol (2014) 0.92
Perineural invasion is a prognostic factor in intrahepatic cholangiocarcinoma. World J Surg (2008) 0.90
The clinical features and optimal treatment of anorectal malignant melanoma. Ann Surg Treat Res (2014) 0.87
Locoregional lymphadenectomy in the surgical management of anorectal melanoma. Ann Surg Oncol (2013) 0.81
Primary rectal melanoma. J Surg Case Rep (2011) 0.81
Incidence and survival patterns of rare anal canal neoplasms using the surveillance epidemiology and end results registry. Am Surg (2013) 0.81
Incidence, Surgical Treatment, and Prognosis of Anorectal Melanoma From 1973 to 2011: A Population-Based SEER Analysis. Medicine (Baltimore) (2016) 0.81
Primary gastrointestinal stromal tumor of the liver in an anorectal melanoma survivor: A case report. Oncol Lett (2015) 0.80
Primary anorectal malignant melanoma treated with endoscopic mucosal resection. Intest Res (2015) 0.79
Unexpected post-operative diagnosis of primary rectal melanoma. A case report. G Chir (2014) 0.78
A pilot study of extralevator abdominoperineal excision for primary melanoma of the anorectum. Tech Coloproctol (2014) 0.76
A case report of anorectal malignant melanoma with mucosal skipped lesion. Int J Surg Case Rep (2016) 0.75
Surgical and radiation therapy management of recurrent anal melanoma. J Gastrointest Oncol (2014) 0.75
Primary malignant melanoma of the rectum: report of two cases. Case Rep Surg (2012) 0.75
Should abdominoperineal excision be considered as the initial treatment for a primary anorectal malignant melanoma? J Korean Soc Coloproctol (2011) 0.75
Primary rectal malignant melanoma-case report. Hippokratia (2013) 0.75
Primary anorectal melanoma-a rare entity: case report. J Surg Case Rep (2017) 0.75
Abdominal perineal resection or wilde local excision in primary anorectal malignant melanoma. Case report and review. Ann Med Surg (Lond) (2017) 0.75
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20
Anorectal melanoma. A 64-year experience at Memorial Sloan-Kettering Cancer Center. Dis Colon Rectum (1995) 2.64
A comparison of wide local excision with abdominoperineal resection in anorectal melanoma. Melanoma Res (2004) 2.20
Surgical management of primary anorectal melanoma. Br J Surg (2004) 2.14
Anorectal melanoma--an incurable disease? Dis Colon Rectum (1997) 2.02
What is the best surgical treatment for anorectal melanoma? Int J Colorectal Dis (2003) 1.86
Microarray expression profiling in melanoma reveals a BRAF mutation signature. Oncogene (2004) 1.83
Anorectal melanoma. Cancer (1981) 1.77
Anorectal melanoma: clinical characteristics and results of surgical management in twenty-four patients. Surgery (1990) 1.72
Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Cancer (1999) 1.70
Surgical therapy for anorectal melanoma. J Am Coll Surg (2003) 1.65
Patterns of failure in anorectal melanoma. A guide to surgical therapy. Arch Surg (1990) 1.64
Malignant melanoma of the anus: report of 12 patients and analysis of 255 additional cases. Dis Colon Rectum (1982) 1.58
Anorectal melanoma: surgical management guidelines according to tumour thickness. Br J Cancer (2003) 1.37
Biochemotherapy in patients with metastatic anorectal mucosal melanoma. Cancer (2004) 1.30
The surgical treatment of anorectal malignant melanoma. Br J Surg (1986) 1.12
Criteria for extramural perineural invasion as a prognostic factor in rectal cancer. Br J Surg (2001) 1.08
Response of stage IV anal mucosal melanoma to chemotherapy. Lancet Oncol (2005) 1.04
Prognostic evaluation of perineural invasion in rectal cancer. Am J Surg (1993) 1.00
BRAF mutations distinguish anorectal from cutaneous melanoma at the molecular level. Gastroenterology (2004) 0.87
Clinicopathologic study of perineural invasion in rectal cancer. Kurume Med J (1992) 0.83
Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol (2009) 23.08
Distinct sets of genetic alterations in melanoma. N Engl J Med (2005) 17.26
Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry. J Clin Oncol (2005) 8.08
Clinicopathologic correlates of solitary fibrous tumors. Cancer (2002) 5.96
Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol (2005) 4.79
Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis. Am J Surg Pathol (2005) 3.99
KIT as a therapeutic target in metastatic melanoma. JAMA (2011) 3.49
A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. Ann Surg (2006) 3.34
Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res (2006) 3.32
Genomic and biological characterization of exon 4 KRAS mutations in human cancer. Cancer Res (2010) 3.24
Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Ann Surg (2010) 2.99
Comparative genomic analysis of primary versus metastatic colorectal carcinomas. J Clin Oncol (2012) 2.74
Hospital and surgeon procedure volume as predictors of outcome following rectal cancer resection. Ann Surg (2002) 2.71
Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy. Ann Surg Oncol (2003) 2.69
Clinicopathological features of and risk factors for multiple primary melanomas. JAMA (2005) 2.62
Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection. Dis Colon Rectum (2004) 2.52
Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies. Nat Genet (2009) 2.51
Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol (2009) 2.50
Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol (2010) 2.30
Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer. Surgery (2009) 2.29
Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix. Am J Surg Pathol (2008) 2.27
Laparoscopic versus open distal gastrectomy for gastric cancer: a meta-analysis of randomized controlled trials and high-quality nonrandomized studies. Ann Surg (2012) 2.23
Pancreatic adenocarcinoma: the actual 5-year survivors. J Gastrointest Surg (2007) 2.22
Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg (2005) 2.19
An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin (2004) 2.18
Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg (2003) 2.16
Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome. Cancer Lett (2006) 2.12
The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers. Proc Natl Acad Sci U S A (2009) 2.09
BLM heterozygosity and the risk of colorectal cancer. Science (2002) 2.03
gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity. Cancer Res (2009) 1.98
Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis. J Clin Oncol (2008) 1.97
Metastasis to the adrenal gland: the emerging role of laparoscopic surgery. Ann Surg Oncol (2003) 1.97
Counting alleles to predict recurrence of early-stage colorectal cancers. Lancet (2002) 1.96
Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg (2009) 1.94
cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. J Clin Oncol (2008) 1.93
Rectus flap reconstruction decreases perineal wound complications after pelvic chemoradiation and surgery: a cohort study. Ann Surg Oncol (2005) 1.92
The New American Joint Committee on Cancer/International Union Against Cancer staging system for adenocarcinoma of the stomach: increased complexity without clear improvement in predictive accuracy. Ann Surg Oncol (2012) 1.87
Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients. Ann Surg Oncol (2010) 1.85
Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer? Ann Surg Oncol (2007) 1.84
Accuracy of endorectal ultrasonography in preoperative staging of rectal tumors. Dis Colon Rectum (2002) 1.83
A nomogram that predicts the presence of sentinel node metastasis in melanoma with better discrimination than the American Joint Committee on Cancer staging system. Ann Surg Oncol (2005) 1.83
Atypical spitzoid melanocytic tumors with positive sentinel lymph nodes in children and teenagers, and comparison with histologically unambiguous and lethal melanomas. Am J Surg Pathol (2009) 1.82
Dermatologic side effects associated with the epidermal growth factor receptor inhibitors. J Am Acad Dermatol (2006) 1.78
Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. J Clin Oncol (2011) 1.78
Desmoplastic melanoma: a pathologically and clinically distinct form of cutaneous melanoma. Ann Surg Oncol (2005) 1.76
L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition. Int J Cancer (2007) 1.76
Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions. Genome Biol (2014) 1.76
Use of surgery among elderly patients with stage IV colorectal cancer. J Clin Oncol (2004) 1.74
Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma. J Clin Oncol (2007) 1.74
Prediction of nonsentinel lymph node status in melanoma. Ann Surg Oncol (2003) 1.74
Surgeon volume compared to hospital volume as a predictor of outcome following primary colon cancer resection. J Surg Oncol (2003) 1.73
Association of survival and disease progression with chromosomal instability: a genomic exploration of colorectal cancer. Proc Natl Acad Sci U S A (2009) 1.72
c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases. Cancer Lett (2008) 1.71
Epidermal growth factor receptor expression and gene amplification in colorectal carcinoma: an immunohistochemical and chromogenic in situ hybridization study. Mod Pathol (2005) 1.67
Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg (2002) 1.66
Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. J Am Coll Surg (2002) 1.65
A single-institution validation of the AJCC staging system for stage IV melanoma. Ann Surg Oncol (2008) 1.64
Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg (2005) 1.64
Close distal margin and rectal cancer recurrence after sphincter-preserving rectal resection. Dis Colon Rectum (2010) 1.64
Primary cutaneous melanoma with regression does not require a lower threshold for sentinel lymph node biopsy. Ann Surg Oncol (2007) 1.63
Stage-IV melanoma and pulmonary metastases: factors predictive of survival. Ann Surg Oncol (2007) 1.63
Residual mesorectal lymph node involvement following neoadjuvant combined-modality therapy: rationale for radical resection? Ann Surg Oncol (2004) 1.62
Extranodal follicular dendritic cell sarcoma: clinical, pathologic, and histogenetic characteristics of an underrecognized disease entity. Virchows Arch (2006) 1.62
Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities. Am J Surg Pathol (2009) 1.62
Multivariate prognostic model for patients with thick cutaneous melanoma: importance of sentinel lymph node status. Ann Surg Oncol (2002) 1.62
Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol (2008) 1.61
Attenuated familial adenomatous polyposis: an evolving and poorly understood entity. Dis Colon Rectum (2002) 1.59
Prognostic significance of depth of gross or microscopic perirectal fat invasion in T3 N0 M0 rectal cancers following sharp mesorectal excision and no adjuvant therapy. Int J Colorectal Dis (2003) 1.59